Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin
structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal
infections including peritonitis, gynecological infections including pelvic inflammatory disease.
GMP Quality CAS 64485-93-4 99% Cefotaxime sodium
Ceftriaxone sodium is a water-soluble β-lactam cephalosporin, which is a non-gastrointestinal, semi-synthetic,
broad-spectrum and long-acting third-generation cephalosporin antibiotic. It is very sensitive to most gram-
positive and negative bacteria, with broad antibacterial spectrum, strong antibacterial action, resistance to
enzyme degradation, low toxicity, strong tissue penetration and long half-life. The β-lactam structure of
ceftriaxone acts on the carboxypeptidase, endopeptidase and transpeptidase of the plasma membrane of
bacterial cells, all of which are involved in cell synthesis and cell division. Through these enzymes, cell wall
defects and cell death are caused, and mucopeptidase synthesis of bacterial cell wall is inhibited to achieve
therapeutic effect. In the treatment of lower respiratory tract infection, skin tissue, urinary tract infection, bone
and joint infection and bacterial septicemia disease has achieved good therapeutic effect.